These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22140658)

  • 1. Clinical parameters of inflammatory bowel disease in children do not correlate with four common polymorphisms of the transforming growth factor β1 gene.
    Liberek A; Jakóbkiewicz-Banecka J; Kloska A; Świderska J; Kmieć Z; Łuczak G; Wierzbicki P; Liberek T; Marek K; Plata-Nazar K; Sikorska-Wiśniewska G; Kamińska B; Węgrzyn G
    Acta Biochim Pol; 2011; 58(4):641-4. PubMed ID: 22140658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor β1 protein and mRNA levels in inflammatory bowel diseases: towards solving the contradictions by longitudinal assessment of the protein and mRNA amounts.
    Liberek A; Kmieć Z; Wierzbicki PM; Jakóbkiewicz-Banecka J; Liberek T; Łuczak G; Plata-Nazar K; Słomińska-Frączek M; Kaszubowska L; Gabig-Cimińska M; Węgrzyn A
    Acta Biochim Pol; 2013; 60(4):683-8. PubMed ID: 24432317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mRNA level of the transforming growth factor β1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children.
    Liberek A; Kmieć Z; Kartanowicz D; Wierzbicki PM; Stanisławowski M; Kaszubowska L; Luczak G; Góra-Gębka M; Landowski P; Szlagatys-Sidorkiewicz A; Liberek T; Kamińska B; Jakóbkiewicz-Banecka J; Węgrzyn G
    Int J Colorectal Dis; 2013 Feb; 28(2):165-72. PubMed ID: 22584294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.
    Eliopoulos DG; Mavroudi I; Pontikoglou C; Ximeri M; Stavroulaki E; Pyrovolaki K; Velegraki M; Spanoudakis M; Goulielmos G; Papadaki HA
    Eur J Haematol; 2009 Dec; 83(6):535-40. PubMed ID: 19614955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta1 and its receptors in patients with ulcerative colitis.
    Stadnicki A; Machnik G; Klimacka-Nawrot E; Wolanska-Karut A; Labuzek K
    Int Immunopharmacol; 2009 Jun; 9(6):761-6. PubMed ID: 19285572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
    Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
    J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of VEGF and TGF-β1 during exclusive enteral nutrition in IBD.
    Wedrychowicz A; Kowalska-Duplaga K; Jedynak-Wasowicz U; Pieczarkowski S; Sladek M; Tomasik P; Fyderek K
    J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):150-5. PubMed ID: 21788755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma.
    Wei YS; Zhu YH; Du B; Yang ZH; Liang WB; Lv ML; Kuang XH; Tai SH; Zhao Y; Zhang L
    Clin Chim Acta; 2007 May; 380(1-2):165-9. PubMed ID: 17368597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of the promoter region of C-509T of transforming growth factor-beta1 gene and ulcerative colitis.
    Tamizifar B; Bagheri-Lankarani K; Naeemi S; Rismankar-Zadeh M; Taghavi A; Ghaderi A
    Arch Iran Med; 2007 Apr; 10(2):171-5. PubMed ID: 17367219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between the TGF-beta1 gene -509C/T polymorphism and tubulointerstitial damage resulting from primary nephrotic syndrome.
    Li Y; Liu FY; Peng YM; Li J; Sun L; Chen X; Duan SB; Ling GH; Guo N; Liu YH
    Ren Fail; 2010 May; 32(4):420-7. PubMed ID: 20446778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor beta1 gene.
    Chang SJ; Chen CJ; Tsai FC; Lai HM; Tsai PC; Tsai MH; Ko YC
    Rheumatology (Oxford); 2008 May; 47(5):617-21. PubMed ID: 18356176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
    Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
    Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of common transforming growth factor beta-1 gene polymorphisms in gastric and duodenal ulcer disease: pilot study.
    Polonikov AV; Ivanov VP; Belugin DA; Khoroshaya IV; Kolchanova IO; Solodilova MA; Tutochkina MP; Stepchenko AA
    J Gastroenterol Hepatol; 2007 Apr; 22(4):555-64. PubMed ID: 17376051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients.
    Brezzi B; Del Prete D; Lupo A; Magistroni R; Gomez-Lira M; Bernich P; Anglani F; Mezzabotta F; Turco A; Furci L; Ceol M; Antonucci F; Abaterusso C; Bonfante L; D'Angelo A; Albertazzi A; Gambaro G
    J Nephrol; 2009; 22(6):747-59. PubMed ID: 19967654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of cytokine mRNA expression in intestinal biopsies of cats with inflammatory enteropathy using quantitative real-time RT-PCR.
    Nguyen Van N; Taglinger K; Helps CR; Tasker S; Gruffydd-Jones TJ; Day MJ
    Vet Immunol Immunopathol; 2006 Oct; 113(3-4):404-14. PubMed ID: 16879876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of a CXCL9 polymorphism with pediatric Crohn's disease.
    Lacher M; Kappler R; Berkholz S; Baurecht H; von Schweinitz D; Koletzko S
    Biochem Biophys Res Commun; 2007 Nov; 363(3):701-7. PubMed ID: 17892861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.